Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Femasys Inc. announced its financial results for the quarter and six months ended June 30, 2026, highlighting a significant $30 million private placement to fund its U.S. commercial strategy for FemaSeed and advance the FemBloc clinical program. The company reported progress in strengthening its …